FDA proposes to exclude semaglutide, tirzepatide from compounding list
Go back to FDA proposes to exclude semaglutide, tirzepatide from compounding list| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1163.01 -12.4 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1175.41 | 52 Week High | $88.16 | |||
| Open | $1173.91 | 52 Week Low | $67.88 | |||
| Day High | $1175.00 | P/E | 269.22 | |||
| Day Low | $1153.50 | EPS | $4.32 | |||
| Volume | 1,555,531 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 48.19 -1.19 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.38 | 52 Week High | $59.00 | |||
| Open | $49.45 | 52 Week Low | $32.80 | |||
| Day High | $49.54 | P/E | N/A | |||
| Day Low | $47.98 | EPS | $0.00 | |||
| Volume | 8,284,791 | |||||
